These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 2650821

  • 21. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB, Li CL, Lam MH, Shen TY.
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [Abstract] [Full Text] [Related]

  • 22. Proposed role for leukotrienes in the pathophysiology of multiple systems organ failure.
    Sprague RS, Stephenson AH, Dahms TE, Lonigro AJ.
    Crit Care Clin; 1989 Apr; 5(2):315-29. PubMed ID: 2650820
    [Abstract] [Full Text] [Related]

  • 23. Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats.
    Balsa D, Merlos M, Giral M, Ferrando R, Garcia-Rafanell J, Forn J.
    Drugs Exp Clin Res; 1997 Apr; 23(5-6):191-9. PubMed ID: 9515229
    [Abstract] [Full Text] [Related]

  • 24. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE, Brooks J, Burton JL, Archer CB.
    Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
    [Abstract] [Full Text] [Related]

  • 25. Platelet-activating factor (PAF) antagonistic actions of two new analogs of tetrahydrofurans.
    Tsao PS, Stahl GA, Lefer AM, Salvino J, Pietranico S, Nicolaou KC.
    J Lipid Mediat; 1989 Jan; 1(3):189-99. PubMed ID: 2519893
    [Abstract] [Full Text] [Related]

  • 26. Potent ulcerogenic actions of platelet-activating factor on the stomach.
    Rosam AC, Wallace JL, Whittle BJ.
    Nature; 1989 Jan; 319(6048):54-6. PubMed ID: 3510396
    [Abstract] [Full Text] [Related]

  • 27. The role of platelet-activating factor in the mammalian female reproductive tract.
    Tiemann U.
    Reprod Domest Anim; 2008 Dec; 43(6):647-55. PubMed ID: 18363604
    [Abstract] [Full Text] [Related]

  • 28. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B, Squadrito F, Bussolino F, Calapai G, Altavilla D, Ioculano M, Campo GM, Canale P, Caputi AP.
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
    [Abstract] [Full Text] [Related]

  • 29. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD, Mikulaschek AW.
    Circ Shock; 1986 Mar; 20(3):193-203. PubMed ID: 3802423
    [Abstract] [Full Text] [Related]

  • 30. Platelet activating factor in pulmonary pathobiology.
    McManus LM, Deavers SI.
    Clin Chest Med; 1989 Mar; 10(1):107-18. PubMed ID: 2650961
    [Abstract] [Full Text] [Related]

  • 31. Inhibitory effects of dexamethasone in endotoxic shock and its relation to PAF-acether synthesis in the gastrointestinal tract and lung.
    Ibbotson GC, Wallace JL.
    J Lipid Mediat; 1989 Mar; 1(5):273-82. PubMed ID: 2519897
    [Abstract] [Full Text] [Related]

  • 32. Rolipram and isoproterenol reverse platelet activating factor-induced increases in pulmonary microvascular permeability and vascular resistance.
    Noel PE, Fletcher JR, Thompson WJ.
    J Surg Res; 1995 Jul; 59(1):159-64. PubMed ID: 7630121
    [Abstract] [Full Text] [Related]

  • 33. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock.
    Lefer AM, Lefer DJ.
    Annu Rev Pharmacol Toxicol; 1993 Jul; 33():71-90. PubMed ID: 8494355
    [Abstract] [Full Text] [Related]

  • 34. Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia.
    Stahl GL, Terashita Z, Lefer AM.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):898-904. PubMed ID: 3252036
    [Abstract] [Full Text] [Related]

  • 35. Role of platelet-activating factor in cardiovascular pathophysiology.
    Montrucchio G, Alloatti G, Camussi G.
    Physiol Rev; 2000 Oct; 80(4):1669-99. PubMed ID: 11015622
    [Abstract] [Full Text] [Related]

  • 36. [Induction mechanism of shock: applying the etiology in judgment of the cause of death in forensic practice].
    Tanaka N.
    Nihon Hoigaku Zasshi; 2004 Sep; 58(2):130-40. PubMed ID: 15526767
    [Abstract] [Full Text] [Related]

  • 37. Platelet and plasma platelet-activating factor in sepsis and myocardial infarction.
    Graham RM, Strahan ME, Norman KW, Watkins DN, Sturm MJ, Taylor RR.
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):167-82. PubMed ID: 8012763
    [Abstract] [Full Text] [Related]

  • 38. Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists.
    Heuer HO.
    Lipids; 1991 Dec; 26(12):1369-73. PubMed ID: 1819735
    [Abstract] [Full Text] [Related]

  • 39. Role of leukotrienes and platelet activating factor in gastric mucosal damage and repair.
    Konturek SJ, Brzozowski T.
    J Physiol Pharmacol; 1991 Jun; 42(2):107-33. PubMed ID: 1782413
    [Abstract] [Full Text] [Related]

  • 40. Platelet activating factor (PAF). A possible direct mediator of anaphylaxis in the rabbit and a trigger for the vascular deposition of circulating immune complexes.
    Henson PM, Pinckard RN.
    Monogr Allergy; 1977 Jun; 12():13-26. PubMed ID: 335211
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.